Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study

NCT01107340 is registered in ClinicalTrials.gov with Medacta International SA as lead sponsor.

NCT NCT01107340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01107340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study
Lead sponsor
Medacta International SA
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 31, 2010
Completion date
January 31, 2028
Enrollment
500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arthritis, avascular necrosis, congenital hip dysplasia, fracture of the femoral neck or head, osteoarthritis